Vincristine as a treatment for a large haemangioma threatening vital functions

British Journal of Plastic Surgery

Volumn 57, Issue 2, 2004, Pages 168-171

  Fawcett, S L ^a   Grant, I ^a   Hall, P N ^a   Kelsall, A W R ^a   Nicholson, James C ^a,b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Haemangioma; Vascular anomaly; Vascular tumour; Vincristine

Indexed keywords

PREDNISOLONE; VINCRISTINE;

ARTICLE; BLEEDING; CASE REPORT; COMMON CAROTID ARTERY; FEEDING DISORDER; FEMALE; GASTROSTOMY; HEAD AND NECK TUMOR; HEMANGIOMA; HUMAN; NASOGASTRIC TUBE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SPEECH DEVELOPMENT; SPEECH DISORDER; STERNOCLEIDOMASTOID MUSCLE; ULCER;

EID: 1242285522     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2003.11.003     Document Type: Article

References (14)

1. Perez J, Pardo J, Gomez C. Vincristine-an effective treatment of corticosteroid-resistant life-threatening infantile hemangiomas. Acta Oncologica 2002;41(2):197-9.
2. Moore J, Lee M, Garzon M, et al. Effective therapy of a vascular tumour of infancy with vincristine. J Pediatr Surg 2001;36:1273-6.
3. El-Dessouky M, Azmy AF, Raine PAM, Young DG. Kasabach-Merritt syndrome. J Pediatr Surg 1988;23(2):109-11.
4. Bartoshesky LE, Bull M, Feingold M. Corticosteroid treatment for cutaneous hemangiomas. How effective? Clin Pediatr 1978;17:625-38.
5. Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990;85:491-8.
6. Sadan N, Wolach B. Treatment of hemangiomas of infants with high doses of prednisolone. J Pediatr 1996;128:141-6.
7. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 1998;132:527-30.
8. Grimal I, Duveau E, Enjolras O, Verrett JL, Ginies JL. Effectiveness and dangers of interferon-alpha in the treatment of severe hemangiomas in infants. Arch Pediatr 2000; 7(2):163-7.
9. Frevel T, Rabe H, Uckbert F, Harms E. Giant cavernous hemangioma with Kasabach-Merritt syndrome; a case report and review. Eur J Pediatr 2002;161(5):243-6.
10. Hesselmann S, Micke O, Marquardt T, et al. Kasabach-Merritt syndrome; a review of the therapeutic options and a case report of successful treatment with radiotherapy and interferon alpha. Br J Radiol 2002;75(890):180-4.
11. Jackson IT, Carreno R, Potparic Z, Hussain K. Hemangiomas, vascular malformations and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 1993;91:1216-30.
12. Arnold AM, Kelleher LH, Rendell SG, Levine MN. Acute vincristine neurotoxicity. Lancet 1985;9(8424):346.
13. Crom WR, de Graaf SSN, Synold T, et al. Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic leukemia. J Pediatr 1994;125(4):642-9.
14. Kissen GDN, Wallace WHB. Long term follow up therapy based guidelines. The United Kingdom Children's Cancer Study Group (UKCCSG). Late effects group; 1995.